Further supporting the existing of an EZH2/TSP1 axis in human prostate cancers, we found that TSP1 and EZH2 are expressed significantly lower and higher, respectively, in metastatic CRPC than in localized prostate cancers (Grasso_mCRPC39) (Fig. 6a). This evidence concerns the gene EZH2 and Familial prostate cancer.